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axis 
 
Technique/tool  Principle Refs. to 
Microbiota 
Research  
Other 
Refs.  
16S microbiome 
profiling 
Sequencing of the 16S rRNA gene isolated from gut 
samples (either tissue or fecal samples) is used to provide 
the general composition of the bacteria in the gut from a 
“bird’s eye” perspective (i.e., roughly at the genus level 
and higher taxonomy). This information is a useful starting 
point for gut microbiota investigations. 
1–5
   
Shotgun metagenomic 
sequencing 
Provides a comprehensive description of gut microbial 
communities at the species level as well as the gene 
catalog carried by those members through sequencing of 
DNA isolated from the gut microbiota. Can be used to 
define the “functional potential” of a polymicrobial 
community (e.g., their metabolic complexity, presence of 
classical virulence genes, etc.). 
6–8
  
Shotgun 
metatranscriptomic 
sequencing 
Provides survey of gut microbiome transcriptional activity, 
which acts as a proxy for bacterial physiology. This RNA 
sequencing approach should be used in conjunction with 
metagenomic (DNA) sequencing to provide context to 
expression patterns, and is has been applied in chronic 
diseases, such as inflammatory bowel disease. 
 
9
 
Metabolomics Provides survey of molecules, nutrient sources, and other 
metabolic products that are available in different body 
compartments, including the gut, brain, and circulatory 
systems. 
10,11
  
In vitro bacterial 
culturing 
Culturing of bacteria in vitro allows for fine control of the 
bacteria’s environment, which can be used to determine 
12,13
 
 
 
bacterial metabolism (including the degradation of 
psychiatric drugs) and cooperative growth using signaling 
molecules. 
 
Germ-free and 
antibiotic treated 
mouse models 
Provides ability to test necessity of gut microbiota in 
mediating biological effects, as removal of the gut 
microbiota can be tested to either enhance or suppress 
phenotypes. Germ-free animals must be bred and 
maintained under completely sterile conditions, but 
antibiotic administration has been used to study depletion 
of gut bacteria from animals born with a complete 
microbiota. 
14–18
  
Fecal microbiota 
transfers in mice 
(not clinical FMT) 
The gut microbiota of mammals (e.g., humans or mice, 
etc.) can be transferred to germ-free or antibiotic treated 
rodents through gavage with slurries from donor fecal 
samples. This can be used to test if the gut microbiota is 
sufficient to transfer a phenotype from one mouse to 
another or from a human to a recipient mouse. 
1,2,10,19
  
Monocolonization The colonization of a germ-free mouse with a single 
bacterial species to determine their sufficiency in 
modulating a phenotype. Can be expanded to include gene 
knockouts of specific pathways in genetically tractable 
organisms. 
11,20
  
Probiotic 
administration 
Bacteria can be administered to rodent models through 
gavage or, in some cases, through drinking water to 
suppress adverse neuropsychiatric phenotypes. Stable 
colonization of probiotics is difficult to attain given the 
nature of colonization resistance by the gut microbiota, so 
probiotics may require chronic administration to have an 
appreciable effect. 
21,22
  
Gene knockouts (KO) 
and transgenic 
Useful for studying genes and genetic pathways implicated 
disease or other outcomes. KO and transgenic animals can 
11,17,18,23
  
animals  be used for modelling human diseases associated to 
genetic risks. 
Cre and/or Lox-P 
recombinase animals 
Site, cell type and time-specific recombination system 
widely used for conditional gene-targeting, a 
bioengineering tool repurposed from bacteriophage 
recombination systems. 
23,24
  
CRISPR/Cas9 system Cas9 has been used to induce cell-type (e.g., neurons) 
genome-editing and generation of stable gene knockouts, a 
bioengineering tool adapted from bacterial “immune 
systems” to phage infection. Useful to model disorders 
associated to genetic risks, including ASD.  
 
25
 
Pharmacological 
agents  
Drugs for studying neurocircuitry and neurotransmitter 
involvement. Can have limited site and time specificity 
(e.g., 5-HT receptor agonists, neurotransmitter receptor 
antagonists, or sodium channel blockers). 
19,23,26
   
Vagotomy The surgical severance of the vagus nerve that disrupts 
signaling from various peripheral organs to the brain. 
Different types of vagotomy can be used depending on the 
goal (e.g., truncal vagotomy, selective vagotomy). 
21,27,28
  
Optogenetics Enables genetically engineered cells to express membrane 
bound light-sensitive proteins (opsins) that can affect 
neuronal activity, inhibition, or modulation of intracellular 
signaling in transgenic animals (e.g., Cre-recombinase 
animals). Activity turned on or off by light. 
N/A 
29
 
Chemogenetics Engineered proteins are used to reach neuronal temporal 
and spatial specificity in transgenic animals. Designer 
receptors exclusively activated by designer drugs 
(DREADDs) are the most common tool used to define 
neuronal population activity. 
30
 
31
 
Electrophysiology Technique that explores electrical activity from action 
potentials in neuronal cells in vitro and in vivo (live 
10,22,23
  
behaving animals). 
Golgi staining, Dyes 
and Tracing Proteins 
Tracing tools that can be deliver to nervous system cells 
(e.g., non-specific membrane tracing; Fluorogold and 
Retrobeads; dextran amines). 
32
  
Immediate Early 
Genes (IEG) readouts 
Allows a broad overview of recently activated neurons 
during defined windows of time and in response to a 
specific stimulus.  
33
  
Functional Magnetic 
Resonance (fMRI) 
Whole brain imaging in a live subject for functional 
connectivity measurements. Poor temporal resolution. Not 
cell-type specific. 
34,35
  
Electron microscopy Allows ultrastructure cell morphology and visualization of 
fine synapsis connectivity. 
36,37
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